Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-567-0 | CAS number: 585-88-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2012
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- The genotoxic and teratogenic effects of maltitol in rats
- Author:
- Semir Canimoglu and Eyyup Rencuzogullari
- Year:
- 2 012
- Bibliographic source:
- Toxicology and Industrial Health, 29 (10) 935-943
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Okada et al (2004)
- Version / remarks:
- The study was performed according to Okada et al (2004) based on OECD 414 guidelines with deviations: the treatment period was from gestation day 1 to gestation day 7 (first trimester)
- Deviations:
- yes
- Remarks:
- See "Version/remarks" section for deviations details.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- 4-O-α-D-glucopyranosyl-D-glucitol
- EC Number:
- 209-567-0
- EC Name:
- 4-O-α-D-glucopyranosyl-D-glucitol
- Cas Number:
- 585-88-6
- Molecular formula:
- C12H24O11
- IUPAC Name:
- 4-O-α-D-glucopyranosyl-D-glucitol
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: from Sigma, Batch No. M8892
- Expiration date of the lot/batch: not specified
- Purity test date: not specified
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability under test conditions: not specified
- Solubility and stability of the test substance in the solvent/vehicle: not specified
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: not applicable
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
Maltitol was dossilved in distilled water, no more details.
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: From Medical Sciences, Experimental Research and Application Centre of Cukurova University
- Age at study initiation: 12-16 weeks old
- Weight at study initiation: 210±2.08 g
- Fasting period before study: not specified
- Housing: Plastic Cages (32x46x18 cm)
- Diet (e.g. ad libitum): not detailed
- Water (e.g. ad libitum): not detailed
- Acclimation period:5 days before the beginning of the teratogenicity study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±1°C
- Humidity (%): Not detailed
- Air changes (per hr): not detailed
- Photoperiod (hrs dark / hrs light): 12h/12h
IN-LIFE DATES: Not detailed
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Maltitol was dissolved in distilled water.
VEHICLE
- Justification for use and choice of vehicle (if other than water): no justification was provided
- Concentration in vehicle: not detailed
- Amount of vehicle (if gavage): not applicable
- Lot/batch no. (if required): not specified
- Purity: not specified - Analytical verification of doses or concentrations:
- no
- Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: 1 male / 2 females
- Length of cohabitation: one night
- Further matings after two unsuccessful attempts: no
- Verification of same strain and source of both sexes: not specified
- Proof of pregnancy: vaginal plug referred to as day 0 of pregnancy - Duration of treatment / exposure:
- From gestadion day 1 to gestation day 7 (7 days)
- Frequency of treatment:
- once daily
- Duration of test:
- 19 Days
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 4 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 8 pregnant dams were used per condition
- Control animals:
- yes
- yes, concurrent vehicle
- other: positive control
- Details on study design:
- - Dose selection rationale: no dose selection rationale was provided
- Rationale for animal assignment (if not random): not detailed, randomly
Examinations
- Maternal examinations:
- The weight of pregnant rats was scored four times during the gestation period (GD0, GD6, GD12 and GD19). The rats were killed under ether anaesthesia on GD19.
- Ovaries and uterine content:
- The uterus and ovaries were excised. The number of implantations, live and dead foetuses, were determined. The number of corpora lutea was counted under a binocular digital stereomicroscope.
- Fetal examinations:
- The number of implantations, live and dead foetuses, were determined. The number of corpora lutea was counted under a binocular digital stereomicroscope. The foetuses were weighed and examined for macroscopic external abnormalities. The foetuses were killed with ether treatment and then they were double-stained for skeletal examination using the double staining method according to Okada et al. (2004) with minor modifications. The skin, muscle, fat and internal organs of the foetuses were gently removed. Skeletons were fixed with acetone for 2 weeks and then stained with the double-staining solution consisting of 0.0005% alizarin red, 0.01% alican blue 8GX and 0.05% glacial acetic acid in 70% ethanol for 2 days. The specimens were macerated in 1% potassium hydroxide for 2 days after rinsing with tap water. Finally, the specimens were treated with 0.8% potassium hydroxide and 20% glycerin solution for 5 days to clean soft tissues. Then, the specimens were preserved in glycerin and 70% ethanol (1:1). Skeletons of double stained-foetuses were examined under a stereomicroscope and digitally photographed with a digital stereomicroscope. The skeletal segments were characterized according to Menegola et al. (2001).
- Statistics:
- The t test was used for the statistical significance of a number of corpora lutea, total implantation, empty implantation, live and dead foetuses and a number of abnormal foetuses after the one-way statistical analysis of variance.
- Historical control data:
- No historical data were presented in this study.
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
Maternal developmental toxicity
- Number of abortions:
- effects observed, non-treatment-related
- Pre- and post-implantation loss:
- no effects observed
- Total litter losses by resorption:
- no effects observed
- Early or late resorptions:
- no effects observed
- Dead fetuses:
- no effects observed
- Details on maternal toxic effects:
- The weight of dams linearly increased in the control and all the concentrations of maltitol during the gestation periods. The increase in weight of dams between GD0 and GD19 during gestation was 75 g in the control groups, 63, 68 and 58 g in the maltitol concentrations of 1, 2 and 4 mg/kg bw, respectively (Table 2).
Maternal abnormalities
- Abnormalities:
- no effects observed
Results (fetuses)
- Fetal body weight changes:
- effects observed, non-treatment-related
- External malformations:
- no effects observed
- Skeletal malformations:
- effects observed, treatment-related
- Visceral malformations:
- not examined
- Details on embryotoxic / teratogenic effects:
- Maltitol increased the number of corpora lutea when compared with the control; however, it did not increase the number of total and empty implantations and did not induce the number of live foetuses (Table 1). In total, three dead foetuses (0.42 + 0.29) were shown in two dams treated with 2 g/kg bw ofmaltitol; however, there was no statistical significance. Maltitol decreased the weight of the foetuses at all the concentrations. The weight of the foetuses was recorded at 1.97 + 0.05 in dams treated with 4 g/kg bw of maltitol, while growth retardation and a lack of ossify were also observed in this group. Wave ribs as a skeletal abnormality were observed in three foetuses of dams treated with maltitol at 2 g/kg bw.
The authors suggested in the publication that maltitol caused hyperglycemia and caused embryotoxicity by preventing the embryo nutriment transfer and oxygenation via yolk bladder dysfunction dependent on a high blood sugar level (see the publication for review).
Fetal abnormalities
- Abnormalities:
- no effects observed
Any other information on results incl. tables
Table1. The teratogenic effect of maltitol in rats after intraperitoneal treatment with maltitol during 7 days(fromGD1 toGD7).
|
Maltitol |
|
|||
|
Control |
EMS (50 mg/kg) |
1 g/kg |
2 g/kg |
4 g/kg |
Number of pregnant dams |
8 |
8 |
13 |
12 |
12 |
Corpora lutea |
9.64+1.74 |
12.25+1.04 |
11.23+0.44a |
12.75+0.35b |
11.08+0.45a |
Total implantation |
10.62+0.59 |
10.25+1.12 |
10.46+0.57 |
10.00+0.49 |
10.08+0.55 |
Empty implantation |
0.50+0.26 |
9.25+0.95 |
0.50+0.19 |
0.33+0.14 |
1.00+0.36 |
Live foetuses |
10.12+0.39 |
1.00+0.42 |
10.00+0.55 |
9.41+0.64 |
9.08+0.76 |
Dead foetuses |
– |
– |
– |
0.42+0.29 |
– |
Foetusweight(g) |
2.60+0.007 |
1.74+0.10 |
2.16+0.05b |
2.42+0.83c |
1.97+0.05b |
Litter with abnormal foetuses |
– |
2 |
– |
3 |
6 |
Number of abnormal foetuses |
– |
3d |
– |
3d |
43e |
EMS: ethylmethansulphonate; ap<0.01significantwhen compared with control.; bp<0.001significant when compared with control.; cp<0.05 significant when compared with control.; dSkeletal abnormality (wave ribs); eThe foetuses had growth retardation due to the low body weight.
Table 2. The weight of dams during gestationa.
Gestation period (days) | Control | EMS (50 mg/kg bw) | Maltitol | ||
1 g/kg bw | 2 g/kg bw | 4 g/kg bw | |||
0 | 201.75 ± 5.09 |
221.62 + 7.36 | 203.30 + 4.08 | 216.58 + 2.40 | 212.41 + 3.25 |
6 | 209.50 + 5.61 | 207.25 + 6.55 | 212.30 + 4.46 | 228.25 + 2.57b | 218.75 + 4.08 |
12 | 229.50 + 7.05c | 208.37 + 9.30 | 226.53 + 4.33b | 245.66 + 2.15b | 231.83 + 3.96b |
19 | 276.50 + 6.33b | 220.00 + 9.98 | 266.92 + 5.57b | 284.83 + 3.34b | 262.91 + 4.23b |
EMS: ethylmethanesulphonate.; aSignificant when compared with weight of dams before gestation (GD0).; bp< 0.001.; cp< 0.01.
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions of this study, it was recorded that maltitol was not teratogenic; however, maltitol showed an embryotoxic effect via decreasing the foetuses weight and causing growth retardation at a very high concentration (4 g/kg bw).
This study cannot be used for classification because it does not fully comply with current teratogenicity testing standards: the treatment period was limited to the first trimester of gestation instead of at least from implantation to one day prior to the day of scheduled kill, which should be as close as possible to the normal day of delivery (organogenesis period was not covered during the treatment). In addition, the intraperitoneal route was used instead of the currently recommended oral route and high doses were used (top dose of 4000 mg/kg bw/day). Finally, only 8 pregnant rats were used per condition instead of 16 required in the current guideline. - Executive summary:
In this non GLP compliant in vivo study, the teratogenicity and embryotoxicity of maltitol was investigated in rats according to Okada et al. method (2004).
After mating period with male, the pregnant Sprague-Dawley females rats were intraperitoneally treated with 1, 2 and 4 g/kg bw/day concentrations of maltitol during the first 7 days of gestation (first trimester) to investigate the teratogenicity of maltitol. Ethyl methanesulphonate was used as postive control. The embryos were collected after killing the dams by cervical dislocation under ether anaesthesia on gestation day 19 in order to be evaluated.
The weight of dams linearly increased in the control and all the concentrations of maltitol during the gestation periods. The increase in weight of dams between GD0 and GD19 during gestation was 75 g in the control groups, 63, 68 and 58 g in the maltitol concentrations of 1, 2 and 4 mg/kg bw, respectively.
Maltitol increased the number of corpora lutea when compared with the control; however, it did not increase the number of total and empty implantations and did not induce the number of live foetuses. In total, three dead foetuses (0.42 + 0.29) were shown in two dams treated with 2 g/kg bw ofmaltitol; however, there was no statistical significance. Maltitol decreased the weight of the foetuses at all the concentrations. The weight of the foetuses was recorded at 1.97 + 0.05 in dams treated with 4 g/kg bw of maltitol, while growth retardation and a lack of ossify were also observed in this group. Wave ribs as a skeletal abnormality were observed in three foetuses of dams treated with maltitol at 2 g/kg bw. The authors suggested in the publication that maltitol caused hyperglycemia and caused embryotoxicity by preventing the embryo nutriment transfer and oxygenation via yolk bladder dysfunction dependent on a high blood sugar level (see the publication for review).
Under the experimental conditions of this study, it was recorded that maltitol was not teratogenic; however, maltitol showed an embryotoxic effect via decreasing the foetuses weight and causing growth retardation at a very high concentration (4 g/kg bw).
This study cannot be used for classification because it does not fully comply with current teratogenicity testing standards: the treatment period was limited to the first trimester of gestation instead of at least from implantation to one day prior to the day of scheduled kill, which should be as close as possible to the normal day of delivery (organogenesis period was not covered during the treatment). In addition, the intraperitoneal route was used instead of the currently recommended oral route and high doses were used (top dose of 4000 mg/kg bw/day). Finally, only 8 pregnant rats were used per condition instead of 16 required in the current guideline.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.